Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Awada

Showing results (171-180 of 311) with videos related to

Pageof 32
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Phase I trial of sorafenib and gemcitabine in advanced solid tumors with an expanded cohort in advanced pancreatic cancerLillian L Siu, Ahmad Awada, Chris H Takimoto, et al.
Journal of Clinical Pharmacology|September 22, 2006
Pharmacokinetics of tipifarnib after oral and intravenous administration in subjects with advanced cancerSteven Zhang, Peter Zannikos, Ahmad Awada, et al.
Molecular and Clinical Oncology|September 3, 2016
Testicular germ cell tumor: Short and long-term side effects of treatment among survivorsThierry Gil, Spyridon Sideris, Fouad Aoun, et al.
Breast Cancer : Basic and Clinical Research|July 12, 2016
Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate Versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast CancerChris Twelves, Ahmad Awada, Javier Cortes, et al.
Cancer Chemotherapy and Pharmacology|May 1, 2008
Phase I dose escalation study of weekly ixabepilone, an epothilone analog, in patients with advanced solid tumors who have failed standard therapyAhmad Awada, Martine J Piccart, Suzanne F Jones, et al.
ESMO Open|November 15, 2018
Risk factors for the development of brain metastases in patients with HER2-positive breast cancerChristian Maurer, Lorraine Tulpin, Michel Moreau, et al.
Gynecologic Oncology Reports|February 13, 2025
Recurrence and survival in high-intermediate risk endometrial cancers with isolated tumor cell lymph node metastasisAhmad Awada, Fernando O Recio, Theresa M Kuhn, et al.
Cancer Treatment Reviews|August 10, 2020
Metronomic chemotherapy for patients with metastatic breast cancer: Review of effectiveness and potential use during pandemicsJohny E Fares, Paul El Tomb, Lana E Khalil, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 3, 2024
Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancerTheresa M Kuhn, Sarfraz Ahmad, Fernando O Recio, et al.
The Lancet. Oncology|April 28, 2009
Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II studyBella Kaufman, Maureen Trudeau, Ahmad Awada, et al.
Pageof 32

Showing results (171-180 of 311) with videos related to

Sort By:
Pageof 32
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Phase I trial of sorafenib and gemcitabine in advanced solid tumors with an expanded cohort in advanced pancreatic cancerLillian L Siu, Ahmad Awada, Chris H Takimoto, et al.
Journal of Clinical Pharmacology|September 22, 2006
Pharmacokinetics of tipifarnib after oral and intravenous administration in subjects with advanced cancerSteven Zhang, Peter Zannikos, Ahmad Awada, et al.
Molecular and Clinical Oncology|September 3, 2016
Testicular germ cell tumor: Short and long-term side effects of treatment among survivorsThierry Gil, Spyridon Sideris, Fouad Aoun, et al.
Breast Cancer : Basic and Clinical Research|July 12, 2016
Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate Versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast CancerChris Twelves, Ahmad Awada, Javier Cortes, et al.
Cancer Chemotherapy and Pharmacology|May 1, 2008
Phase I dose escalation study of weekly ixabepilone, an epothilone analog, in patients with advanced solid tumors who have failed standard therapyAhmad Awada, Martine J Piccart, Suzanne F Jones, et al.
ESMO Open|November 15, 2018
Risk factors for the development of brain metastases in patients with HER2-positive breast cancerChristian Maurer, Lorraine Tulpin, Michel Moreau, et al.
Gynecologic Oncology Reports|February 13, 2025
Recurrence and survival in high-intermediate risk endometrial cancers with isolated tumor cell lymph node metastasisAhmad Awada, Fernando O Recio, Theresa M Kuhn, et al.
Cancer Treatment Reviews|August 10, 2020
Metronomic chemotherapy for patients with metastatic breast cancer: Review of effectiveness and potential use during pandemicsJohny E Fares, Paul El Tomb, Lana E Khalil, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 3, 2024
Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancerTheresa M Kuhn, Sarfraz Ahmad, Fernando O Recio, et al.
The Lancet. Oncology|April 28, 2009
Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II studyBella Kaufman, Maureen Trudeau, Ahmad Awada, et al.
Pageof 32